fbpx
  • Home
  • Study Details
Open

Pilot Study: Chemotherapy and Cognition

To examine whether cancer patients who have recently completed chemotherapy display cognitive impairments as compared to age-matched healthy control participants. Participants will participate in one approximately 2-3 hour study session, which will include questionnaires, cognitive computer tasks and neuropsychology tests.

Age & Gender

  • 18 years ~ 75 years
  • Female

Location

North Carolina (Statewide)

What will be asked of you

Cognitive testing and questionnaires

Incentives

$25 check

In-person visits : 1
Total length of participation : 2-3 hours

Looking for Specific Volunteers

Able to participate:

  • Recently completed chemotherapy treatment for breast cancer (within the last 1-12 months)
  • Female, age 18-75, proficient in English
  • Not colorblind

Not eligible if:

  • None

Looking for Healthy Volunteers

Requirements for healthy volunteers are different than for those with a specific condition. If you are interested in becoming a healthy volunteer for this study, use the below categories to determine if you are able to participate.

Able to participate:

  • Never received a diagnosis of cancer or chemotherapy treatment
  • Female, age 18-75, proficient in English
  • Not colorblind

Not eligible if:

  • None

Contact the Team

Visit Location

  •  Emma Armstrong-Carter

100% Remote (online, phone, text)

Additional Study Information

Principal Investigator

Keely Muscatell
Psychology and Neuroscience

Study Topics

Aging
Cancer (Breast)
Healthy Volunteer or General Population
Women's Health

IRB Number

17-1730

logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research
Research for Me logo

Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.